BrainCore Neurofeedback Therapy of Connecticut
- Neurofeedback Therapy
- Migraine Treatment
Read the Neurofeedback Therapy guide for the educational context behind this treatment category.
Connecticut
Looking for neurofeedback therapy for migraines in Connecticut means checking both location and headache experience. Evidence for migraine relief from neurofeedback remains limited, and a treatment listing does not establish that an office evaluates migraines. Ask whether the provider coordinates with your headache clinician and tracks headache days, medication use, and daily functioning. For an explanation of the mechanism and broader evidence, see the national neurofeedback therapy hub.
The listings here cluster in Fairfield County, including the Stamford and Bridgeport metro areas, and greater New Haven and the shoreline farther east. They do not show even coverage across greater Hartford, the northwest hills, or northeastern Connecticut. From those regions, appointments may involve traveling across the state rather than visiting a nearby office. Compare the actual treatment address and repeat travel before committing; missing listings do not establish that a region has no providers.
Neurofeedback is generally an outpatient service in behavioral health, integrative care, or wellness offices. In Connecticut, check the practitioner's underlying professional license and scope of practice, alongside federal device rules, rather than treating a training certificate as permission to manage migraines. Ask the Connecticut Department of Public Health about the proposed provider's role and supervision. A device's regulatory status does not by itself establish evidence for its use in migraine care.
Use Connecticut eLicense and Department of Public Health disciplinary records to check credentials. Relevant bodies include the Connecticut Medical Examining Board for physicians and physician assistants, the Board of Examiners for Nursing for nurses, and the Board of Examiners of Psychologists for psychologists. These checks establish license status and disclose public disciplinary actions, but do not establish migraine expertise.
Before booking, identify who selects and supervises the protocol, what equipment is used, and who supplies it. Request written risks, a plan for worsening symptoms or lack of benefit, and an itemized quote covering assessment, any brain mapping, training, and reviews. Neurofeedback is often cash pay, so confirm coverage before committing.
Regenerated.com does not sell organic listing order. Featured placements are labeled and capped. Verified means credential checks, not spending, and Regenerated.com is free for patients. Inclusion is not an endorsement. For help interpreting the directory, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
The Connecticut Medical Examining Board investigates TMS clinics for supervision lapses and off-label advertising. The Department of Consumer Protection and attorney general pursue CUTPA actions against neurofeedback providers who promise cures for autism, ADHD, or PTSD beyond what evidence supports. Connecticut insurers, including state employee plans, require documented treatment-resistant depression before covering TMS for major depressive disorder. Wellness and integrative clinics offering CES or tDCS face scrutiny when their marketing implies FDA-cleared status.
Treatment nearby
More in this state
Nationwide
Neurofeedback Therapy clinics across the US